how to titrate off semaglutide Taper GLP-1 Medications: Stopping, Switching, and Preventing Weight Regain How to Stop Weight Regain

Dr Paul Joyce: Yeah, so the clinical studies have shown that essentially for really chronic kidney disease, people that also have diabetes and kidney disease that can really suppress the progression of that disease

Food and Drug Administration (FDA) has approved semaglutide, a glucagon-like peptide receptor agonist (GLP-1RA), to treat type 2 diabetes mellitus (T2DM) and obesity

Stay Hydrated : Aim for 64-80 ounces of water daily to reduce side effects and support your body

According to Health Canada's May 1 announcement, seven other generic semaglutide submissions from different companies remain under review, with regulatory decisions expected "in the coming weeks and months" [Source: canada.ca/en/health-canada/news/2026/05/canada-approves-second-generic-semaglutide-the-first-g7-country-to-do-so.html]